Aptuit to expand API capacity in UK, Italy due to increasing demand

By Zachary Brennan

- Last updated on GMT

Aptuit to expand API capacity in UK, Italy due to increasing demand
Connecticut-based CMO Aptuit opened a 1600L/1000L reactor stream at its API facility in Oxford, UK, and increased throughput at its 400L reactors at its site in Verona, Italy.

Jonathan Goldman, CEO of Aptuit, explained that the API capacity expansions come thanks to a 300% annual increase in demand for its APIs and for the company’s integrated candidate-to-IND development solution.
Goldman explained that Aptuit’s strategy will allow for increased throughput of integrated development programs, as well as to deliver standalone API at 40-120 kg batch scale for early to mid-stage clinical trials.

There is a gap in the market for high quality API at this scale, and Aptuit is delighted to serve this need​,” he said.

Related news

Show more

Related products

show more

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Addressing Challenges with Clinical In-Use Testing

Addressing Challenges with Clinical In-Use Testing

Content provided by Lonza | 12-Oct-2023 | White Paper

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Related suppliers

Follow us

Products

View more

Webinars